纸质出版日期:2024-06-30,
网络出版日期:2024-05-24,
收稿日期:2024-02-08,
移动端阅览
中华中医药学会血液病分会, 中华中医药学会血液病创新研究与转化平台. 中医治疗血液病名家学术观点撷菁Ⅳ[J]. 北京中医药大学学报, 2024,47(6):813-817.
China Association of Chinese Medicine Blood Disease Branch, Hematological Diseases′ Innovative Research and Transformation Platform of China Association of Chinese Medicine. Essential viewpoints of prestigious experts on treating hematological diseases using traditional Chinese medicine Ⅳ[J]. Journal of Beijing University of Traditional Chinese Medicine, 2024,47(6):813-817.
中华中医药学会血液病分会, 中华中医药学会血液病创新研究与转化平台. 中医治疗血液病名家学术观点撷菁Ⅳ[J]. 北京中医药大学学报, 2024,47(6):813-817. DOI: 10.3969/j.issn.1006-2157.2024.06.012.
China Association of Chinese Medicine Blood Disease Branch, Hematological Diseases′ Innovative Research and Transformation Platform of China Association of Chinese Medicine. Essential viewpoints of prestigious experts on treating hematological diseases using traditional Chinese medicine Ⅳ[J]. Journal of Beijing University of Traditional Chinese Medicine, 2024,47(6):813-817. DOI: 10.3969/j.issn.1006-2157.2024.06.012.
为更好地传承与发展名老中医学术思想,中华中医药学会血液病分会、中华中医药学会血液病创新研究与转化平台对陶淑春、顾振东、吴志奎、虞荣喜、周仲瑛5位教授的学术思想与临床诊疗经验进行总结。其中,陶淑春教授遵循病机,结合脏腑及部位诊治,在临证中重视活血化瘀法的应用;顾振东教授创立急性白血病辨证体系并总结脉证规律,提倡中西医结合治疗本病;吴志奎教授提出地中海贫血的病机及治法,应用益髓生血颗粒治疗本病,取得较好疗效;虞荣喜教授提出白血病的中医辨证体系,实现中西医结合治疗本病;周仲瑛教授完善中医内科学辨证论治体系,创立中医病机辨证学说,应用“瘀热”学说及“癌毒论”治疗血液病。本研究的目的是培养和提高中医血液病学后备人才的能力、推动学科建设,同时,为中医药事业的传承与发展提供宝贵的财富。
The China Association of Chinese Medicine Blood Disease Bran
ch and Hematological Diseases′ Innovative Research and Transformation Platform summarized the academic thoughts and experiences of clinical diagnosis and treatment from five professors to better inherit and develop the academic thoughts of prestigious traditional Chinese medicine (TCM) practitioners. These professors include TAO Shuchun
GU Zhendong
WU Zhikui
YU Rongxi
and ZHOU Zhongying. Professor TAO Shuchun researches the pathogenesis
combines the diagnosis and treatment of zang-fu viscera and parts
and attaches great significance to activating blood and resolving stasis. Professor GU Zhendong established a dialectical system for acute leukemia and summarized the laws of pulse syndrome
advocating combining TCM and Western medicine to treat this disease. Professor WU Zhikui proposed the pathogenesis and treatment of thalassemia and was the first to apply
Yisui Shengxue
Granules to treat this disease and achieved good results. Professor YU Rongxi proposed a TCM syndrome differentiation system for leukemia and integrated TCM and Western medicine to treat this disease. Professor ZHOU Zhongying improved the system for syndrome differentiation and treatment in internal medicine of TCM
established the theory of TCM pathogenesis and syndrome differentiation
and applied the theories of "stasis heat" and "cancer toxin" to treat blood disease. The purpose of this initiative is to cultivate and improve the capacity of reserve talents in the hematology of TCM to promote discipline construction. Simultaneously
this initiative provides extremely valuable insights for the inheritance and development of TCM.
中医血液病名老中医学术思想诊疗经验传承
hematological diseases of traditional Chinese medicineprestigious traditional Chinese medicine practitioneracademic thoughtexperience of diagnosis and treatmentinheritance
中华中医药学会血液病分会.中医治疗血液病名家学术观点撷菁[J].北京中医药,2021,40(5):466-469.
中华中医药学会血液病分会.中医治疗血液病名家学术观点撷菁Ⅱ[J].北京中医药大学学报,2022,45(4):421-427.
中华中医药学会血液病分会.中医治疗血液病名家学术观点撷菁Ⅲ[J].北京中医药大学学报,2023,46(12):1772-1776.
李凤珍.陶淑春教授治疗原发性血小板减少性紫癜的经验总结[D].沈阳:辽宁中医学院,2005.
陶淑春.紫癜汤治疗原发性血小板减少性紫癜46例[J].辽宁中医杂志,1997,24(5):19.
李海燕,陶淑春.紫癜冲剂治疗免疫性血小板减少性紫癜的临床研究[J].辽宁中医杂志,2002,29(1):33-34.
杨丽.陶淑春教授治疗过敏性紫癜的经验总结[D].沈阳:辽宁中医学院,2005.
张聪,陶淑春.中西医结合治疗过敏性紫癜156例[J].辽宁中医药大学学报,2013,15(6):201-203.
李海燕,陶淑春.活血化瘀法为主治疗特发性血小板减少性紫癜的临床观察[J].辽宁中医杂志,2007,34(6):788.
李海燕.陶淑春教授活血化瘀法治疗原发性血小板减少性紫癜经验总结[D].沈阳:辽宁中医学院,2002.
李海燕,陶淑春.陶淑春治疗原发性血小板减少性紫癜的经验[J].辽宁中医杂志,2003,30(1):16-17.
徐瑞荣,顾振东,焦中华,等.中医辨证分型配合HA方案治疗急性非淋巴细胞性白血病50例[J].中国中西医结合杂志,1995,15(5):302-303.
徐瑞荣,顾振东,焦中华,等.益气养阴清热法合化疗治疗急性髓细胞白血病[J].浙江中西医结合杂志,2003,13(9):539-540.
唐由君,顾振东,焦中华,等.中西医结合治疗急性非淋巴细胞白血病152例[J].山东中医药大学学报,1998,22(6):436-437.
唐由君,顾振东,李琰,等.150例急性白血病脉诊的临床研究[J].上海中医药杂志,1989,22(1):8-10.
郑翠娥.顾振东辨证治疗原发性血小板减少性紫癜经验[J].山东中医学院学报,1996,20(4):247-248.
唐由君,顾振东,焦中华.62例血小板减少性紫癜辨治体会[J].山东中医杂志,1993,12(6):14-15.
史大卓,李芮,顾振东.再生障碍性贫血的中医药治疗[J].山东中医药大学学报,1990,14(4):30-3170.
吴志奎,张新华,方素萍,等.基于“肾生髓、髓生血”理论治疗地中海贫血[J].世界中医药,2014,9(6):717-721.
顾恪波,程艳玲,孙玉雯,等.基于“肾藏精、生髓”理论辨治地中海贫血的思路探析[J].中医杂志,2021,62(19):1690-1693.
顾恪波,程艳玲,孙玉雯,等.吴志奎“益髓生血”理论治疗地中海贫血应用及机制[J].北京中医药,2021,40(4):386-388.
吴志奎.中医药对边远民族地区人口与健康的贡献——益髓生血治疗地中海贫血取得重大进展[J].亚太传统医药,2008,4(11):4-8.
吴志奎,黄有文,蔡辉国,等.补肾益髓法治疗β-地中海贫血分子基础与临床研究[J].医学研究通讯,2002,31(6):24-25.
程艳玲. 从造血干细胞增殖及造血微环境探讨中药治疗β地中海贫血的分子机制[D].北京:中国中医科学院,2017.
史亦谦,邓旻,虞荣喜,等.中西医结合治疗急性髓性白血病临床分析[J].中国中西医结合杂志,2000,20(5):376-377.
虞荣喜,周郁鸿,朱宁希,等.造血干细胞移植联合中医中药治疗恶性血液病12例[J].中国中西医结合杂志,2001,21(2):90-93.
虞荣喜,周郁鸿,林圣云,等.人类白细胞抗原半相合亲缘性骨髓移植联合中药治疗白血病的临床观察[J].中国中西医结合杂志,2006,26(7):600-603.
杨宏,庄海峰,胡致平,等.中西医结合治疗骨髓移植后带状疱疹[J].浙江中西医结合杂志,2010,20(3):175-176.
周仲瑛.中医内科学[M].北京:中国中医药出版社,2003:5-62.
周学平,叶放,郭立中,等.以病机为核心构建中医辨证论治新体系——国医大师周仲瑛教授学术思想探讨[J].中医杂志,2011,52(18):1531-1534.
周仲瑛,周学平,郭立中,等.中医病机辨证新体系的构建及临床应用[J].江苏中医药,2019,51(2):1-4.
吴勉华,过伟峰,周学平,等.研究周仲瑛“瘀热”学说的思路与方法[J].中华中医药杂志,2009,24(10):1319-1321.
周仲瑛.活血祛瘀法的辨证应用[J].江苏中医药,2023,55(11):1-5.
赵智强,李嘉.略论周仲瑛教授的“癌毒”学说及其临床运用[J].新中医,1998,30(10):7-9.
李柳,程海波,叶放,等.从病机辨证探析国医大师周仲瑛复法组方辨治肿瘤的经验[J].南京中医药大学学报,2021,37(5):765-768.
倪海雯,朱垚,郭立中.周仲瑛癌毒学说在恶性淋巴瘤中的运用[J].安徽中医药大学学报,2017,36(5):38-40.
惠逸帆,倪海雯,程海波.基于癌毒病机理论辨治恶性淋巴瘤探析[J].中国中医药信息杂志,2023,30(3):142-145.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构